Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 months ago

Possible Interaction: Pancreatic Polypeptide and Secretin

Research Papers that Mention the Interaction

Somatostatin, PYY and pancreatic polypeptide are inhibitory regulators, acting either on the release of secretin and CCK or on the action of the two stimulatory hormones.
Pancreatology  •  2001  |  View Paper
We conclude that there is a marked difference in … exocrine pancreas in man and the dog, that PP may play … of pancreatic protein secretion in man and of both bicarbonate and protein secretion in the dog, and … on the exocrine pancreas can be mimicked by its C-terminal hexapeptide.
Scandinavian journal of gastroenterology  •  1982  |  View Paper
In DU, secretin caused a nonsignificant increase in plasma pancreatic polypeptide concentration and markedly decreased gastric acid output.
Digestive Diseases and Sciences  •  2005  |  View Paper
OBJECTIVE Intravenously administered secretin stimulates pancreatic polypeptide (PP) release in patients with endocrine enteropancreatic tumors, but data in patients with nontumorous disorders are controversial.
European journal of endocrinology  •  1999  |  View Paper
In diabetic patients plasma levels of pancreatic polypeptide (PP) increased four fold after intramuscular injection of secretin (50 CHRU, Eisai Co.) in spite of the lack of response of plasma insulin, plasma glucagon and blood glucose levels.
Endocrinologia japonica  •  1980  |  View Paper
PYY and NPY, but not pancreatic polypeptide , starting at nanomolar concentrations, caused a 40-50% inhibition of secretin- , vasoactive intestinal polypeptide-, prostaglandin E2-, and forskolin-induced increases in chief cell adenosine 3',5'-cyclic monophosphate (cAMP) content and pepsinogen secretion.
The American journal of physiology  •  1991  |  View Paper
In addition, BPP inhibited the potentiation of amylase secretion caused by the combination of carbachol plus secretin or vasoactive intestinal peptide.
This may be a possible … of the inhibitory effect of BPP on secretin-induced pancreatic enzyme secretion shown in vivo, since pancreatic enzyme secretion stimulated by secretin under experimental conditions may be the result of potentiation of enzyme release produced by the peptide in combination with a cholinergic stimulant.
The American journal of physiology  •  1987  |  View Paper
The two lowest doses of pancreatic polypeptide (PP), which produced blood levels lower than measured after a meal, significantly inhibited the pancreatic responses to secretin , caerulein, HCl, and L-phenylalanine; the highest dose of PP inhibited the responses to bethanechol and sodium oleate.
The American journal of physiology  •  1984  |  View Paper
Bovine pancreatic polypeptide and its C‐terminal hexapeptide also inhibited secretin and caerulein‐induced pancreatic secretion in a dose‐dependent manner.
The Journal of physiology  •  1981  |  View Paper
BPP (2-5 mug/kg-h) inhibited pancreatic water-bicarbonate and protein secretions induced by an infusion of secretin plus cholecystokinin.
Basal pancreatic secretion of dogs was inhibited by BPP (1-10 mug/kg-h) inhibited pancreatic protein secretion but often showed a biphasic action on water-bicarbonate response, an initial augmentation followed by reduction.
The American journal of physiology  •  1977  |  View Paper